Skip to main content

and
  1. No Access

    Article

    Adjuvant therapy in renal cell carcinoma: the perspective of urologists

    Until recently, there was no approved adjuvant therapy (AT) for renal cell carcinoma (RCC) unless sunitinib was approved in the US. We evaluated clinical opinion and estimated use regarding different treatment...

    Annabel Spek, B. Szabados, J. Casuscelli in International Journal of Clinical Oncology (2019)